Alessandra Bosch/LinkedIn
Jul 22, 2026, 09:29
Alessandra Bosch: Presenting the Latest Evidence in Pediatric Anticoagulation at ISTH 2026
Alessandra Bosch, Attending Physician at Zurich Children’s Hospital, Clinician Scientist at University of Zurich, shared on LinkedIn:
”What a HOT week at ISTH 2026 in Paris!
Grateful for the chance and honour to give a state-of-the-art talk on periprocedural anticoagulation management in children, and to present our poster on real-world rivaroxaban use in children to such an engaged community.
But beyond the science, ISTH is always about the people!
Reconnecting with long-time colleagues, and making new connections that will turn into future collaborations.
Thank you to everyone who stopped by to chat, ask questions, or just say hello.
On to the next one.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios AndreadisÖ‰ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI